Ansamitocin P 3'

• UNSPSC Description:

  Ansamitocin P 3' (Antibiotic C 15003P3') is an anti-tumor antibiotic. Ansamitocin P 3' prolongs the survival of mice with leukemia P388, melanoma B16, leukemia L1210, sarcoma 180, Ehrlich carcinoma and mast cell tumor P815[1].

• Target Antigen:

  Antibiotic

• Type:

  ADC Related

• Related Pathways:

  Anti-infection

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cancer; Infection

• Assay Protocol:

  https://www.medchemexpress.com/Ansamitocin-P-3_acute_.html

• Purity:

  87.63

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@]1([C@@](CC(N(C(C=C2C=C3OC)=C3Cl)C)=O)([H])OC(CCC)=O)[C@H]([C@@H]([C@](OC4=O)([H])C[C@]([C@](/C=C/C=C(C)/C2)([H])OC)(N4)O)C)O1

• Molecular Weight:

  635.14

• References & Citations:

  [1]Asai M, et al. Isolation, chemical characterization and structure of ansamitocin, a new antitumor ansamycin antibiotic[J]. Tetrahedron, 1979, 35(9): 1079-1085.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  66547-09-9